Is a complete YARW research report available?

No complete published report is available for Yarrow Bioscience, Inc. (YARW) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Yarrow Bioscience, Inc. (YARW)

NASDAQ: YARW · USD

$33.0

+2.54 (+8.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first YARW analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	92.4M
Shares out	2.8M
Volume	22,085
Beta	2.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Market cap: 92.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All YARW indicators

Market & fundamental data

Available fields

Groups with data

Currency

USD

Showing 97 of 97 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001566044
Company name	Yarrow Bioscience, Inc.
Country	United States
Country code	US
Cusip	92941V407
Exchange	NASDAQ
Financial currency	USD
First seen	2026-07-30
Industry	Biotechnology
Isin	US92941V4077
Last refreshed	2026-07-31
Market cap	$92.4M
Market cap category	Micro-Cap
Price	$32.99
Price currency	USD
Sector	Healthcare
Sector PE	45.21
Sector PE Fwd	23.64
Symbol	YARW
Website	https://www.yarrowbioscience.com

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-18.8%
Cagr3y	-34.38%
Cagr5y	-52.86%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
WACC	15.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-18.79%
200-day SMA	28.3
3Y total return	-71.75%
50-day SMA	33.89
50-day SMA vs 200-day SMA	50over200
5Y total return	-97.67%
All Time High	14,580
All Time High Change	-99.77%
All Time High Date	2020-03-10
All Time Low	14.03
All Time Low Change	135.22%
All Time Low Date	2025-09-09
ATR	4.06
Beta	2.01
Beta1y	1.86
Beta2y	1.37
Ch YTD	13.74
High	34.36
High52	46.95
High52 Date	2026-07-23
High52ch	-29.73%
Low	29.8
Low52	14.03
Low52 Date	2025-09-09
Low52ch	135.22%
Ma50ch	-2.65%
Price vs 200-day SMA	16.56%
RSI	47.76
RSI Monthly	30.2
RSI Weekly	51.88
Sharpe ratio	0.53x
Sortino ratio	0.74
Tr YTD	101.6
Tr1m	80.61%
Tr1w	26.65%
Tr3m	83.9%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares Out	2,800,000
Short Shares	6.57

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	46,709.75x
Ch1m	1.9
Ch1w	-28.55
Ch1y	-54.18
Ch3m	3.76
Ch3y	-84.06
Ch5y	-98.69
Ch6m	16.47
Change	8.34%
Change From Open	9.64
Close	30.45
Days Gap	-1.18
Dollar Volume	728,584.2
F Score	0
Founded	2,021
Is Primary Listing	1
Is Spac	No
Last Split Date	2026-07-27
Last Split Type	Reverse
Last10k Filing Date	2026-02-27
Ma150	31.33
Ma150ch	5.31%
Ma20	35.16
Ma20ch	-6.17%
Open	30.09
Position In Range	69.96
Post Close	32.99
Postmarket Change Percent	1.55
Postmarket Price	$33.5
Price Date	2026-07-30
Relative Volume	0.47x
Tr6m	106.43%
Us State	New York
Volume	22,085

Yarrow Bioscience, Inc. (YARW)

Coverage state: Market snapshot only — no published research

Generate the first YARW analysis

Price

Financial snapshot

Fair-value bridge

Latest news · YARW

Valuation

Trading

Next earnings

Sector percentile context